Metamizole, a non-steroidal anti-inflammatory drug with weak anti-inflammatory and spasmolytic effects, is used as an analgesic and antipyretic agent. Many adverse reactions to metamizole, such as early or late-onset systemic reactions and bone marrow suppression, have been identified. In this report, we present a case of systemic reaction after the application of parenteral metamizole (Novalgin(®) ampoule; Sanofi Aventis, İstanbul, Turkey) and discuss the mechanism underlying the reaction.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970554PMC
http://dx.doi.org/10.5152/eurasianjmed.2015.0024DOI Listing

Publication Analysis

Top Keywords

ige-mediated reaction
4
metamizole
4
reaction metamizole
4
metamizole evaluation
4
evaluation patient
4
patient severe
4
severe anaphylaxis
4
anaphylaxis metamizole
4
metamizole non-steroidal
4
non-steroidal anti-inflammatory
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!